Ignite Creation Date:
2024-05-05 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 9:58 AM
Study NCT ID:
NCT00793377
Status:
COMPLETED
Last Update Posted:
2008-11-19
First Post:
2008-11-17
Brief Title:
Neoadjuvant DoxorubicinCyclophosphamide Followed by Docetaxel AC-Doc Versus Dose-Dense Doxorubicin and Docetaxel ADoc in Breast Cancer
Sponsor:
Organization:
German Breast Group